OTC · Medical - Diagnostics & Research

NovelStem International Corp. (NSTM) Stock

$0.01 +30.00% OTC: NSTM Healthcare

NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance.

Valuation

MetricValue
Price$0.01
Market Cap$641322
P/E Ratio0.24
P/B Ratio-0.32
P/S Ratio0.00
EPS (TTM)$0.04
52-Week High$0.04
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-124.80%
ROA-74.30%
ROCE8.50%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.91
Current Ratio0.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$-4.0M$-1.0M$0
Net Profit$-1.0M$-1.0M$-4.0M$-3.0M$2.0M
EPS$-0.03$-0.02$-0.09$-0.07$0.05
Op Margin—-3516.7%-29383.3%-7733.3%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.0M$2.0M$2.0M$0$0
Total Liabilities$0$0$4.0M$5.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$4.0M$4.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.86
FCF Yield-40.26%
Quick Ratio0.05
Interest Coverage-0.77
Return 1Y-50.00%
Return 3Y-95.65%
Return 5Y-96.43%

Ownership

Insiders Held58.57%
Institutions Held0.05%
Institutions Float Held0.12%
Institutional HolderSharesReport Date
FNY Investment Advisers, LLC25,0002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BICTFBiocure Technology Inc. $0.01 +0.00% -2.10 $379088 0.00%
BMCSBioTech Medics, Inc. $0.00 — -13.86 $41071 0.00%
BMMJBody and Mind Inc. $0.00 — -0.11 $29537 0.00%
CHYPFHealth Logic Interactive Inc. $0.02 +0.00% -3.77 $165839 0.00%
DTRKDATATRAK International, Inc. $0.28 +0.00% 2.80 $357840 0.00%

About NovelStem International Corp.

NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.

NovelStem International Corp. is headquartered in US.

NovelStem International Corp. (NSTM) stock trades at $0.01 with a market capitalization of $641322. The stock is valued at a price-to-earnings (P/E) ratio of 0.24, a negative price-to-book of -0.32, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.04, and currently trades 75.0% below its 52-week high.

On profitability, NovelStem International Corp. generates a return on equity (ROE) of -124.80% (not meaningful, as shareholders' equity is negative), return on capital employed of 8.50%.

Official website: www.novelstem.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.